Literature DB >> 25043844

Quantification of IgM molecular response by droplet digital PCR as a potential tool for the early diagnosis of sepsis.

Eduardo Tamayo, Raquel Almansa, Elena Carrasco, Ana Ávila-Alonso, Ana Rodríguez-Fernández, John Wain, María Heredia, Esther Gomez-Sanchez, Susana Soria, Lucia Rico, Verónica Iglesias, Angel Martínez-Martínez, David Andaluz-Ojeda, Jose Ignacio Gómez Herreras, Jose Maria Eiros, Jesús F Bermejo-Martin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25043844      PMCID: PMC4075261          DOI: 10.1186/cc13910

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

Evaluation of host immune response to infection at the molecular level is a promising avenue to obtain diagnostic and prognostic tools for the clinical management of patients with sepsis. A recent report from Cajander and colleagues [1] has shown the potential of HLA-DR mRNA quantification by real-time PCR as a biomarker of immunosuppression in these patients. IgM is the first immunoglobulin produced in response to infection. In a pilot study, we have employed a next generation quantitative PCR method (nanoliter-sized droplet technology paired with digital PCR (ddPCR)) for detecting the early transcriptomic response of IgM in blood from patients with sepsis. Approval for the study protocol for both scientific and ethical aspects was obtained from the Committee for Clinical Research of Hospital Clínico Universitario, Valladolid, Spain. Written informed consent was obtained directly from each patient or a legal surrogate. The target gene transcript was IGHM, which encodes the constant region of the mu heavy chain, which defines the IgM isotype [2]. In blood, the cells producing IgM transcripts are B lymphocytes expressing CD20 [3], which was employed as housekeeping gene. Fifty-five patients with sepsis were recruited, 42 of them presenting criteria of septic shock (Additional file 1). Septic patients were predominantly older males (n = 40, 72.7%; mean age 72 years (standard deviation 9.3)). Mean Sepsis-related Organ Failure Assessment score was 8.4 (standard deviation 2.9). Overall ICU mortality was 34%. Emergency surgery was needed in 54% of cases, with cardiac and abdominal surgery the most frequent (45% and 40%, respectively). Respiratory infection was present in 34.5% of the cases. Frequency of abdominal infection was also 34.5%. Gram-negative bacteria were the most frequent isolated (56. 4% of cases). In parallel, we recruited 20 patients with post-surgical systemic inflammatory response syndrome (SIRS) and 15 healthy controls. Compared to real-time quantitative PCR, ddPCR offers greater precision and reproducibility [4]. ddPCR allowed us to identify the presence of an early molecular response of IgM in the blood of patients with sepsis compared with healthy controls and patients with SIRS. This response was more intense in the most severe patients (Figure 1). When accuracy and the predictive value of the IGHM/CD20 ratio for diagnosing sepsis were analyzed, the area under the receiver operating characteristic curve was 0.72 (95% confidence interval 0.60 to 0.85; P = 0.003; Figure 1). In conclusion, quantification of IgM response at the transcriptomic level by ddPCR represents a promising approach for the early detection of sepsis.
Figure 1

IgM transcriptomic response in the presence/absence of sepsis. Left: comparison of immunoglobulin (Ig)M transcriptomic response between groups. HC, healthy control (n = 15); SIRS, systemic inflammatory response syndrome (n = 20); SEPSIS SOFA < =10, Sepsis with Sepsis-related Organ Failure Assessment score ≤10 (n = 39); SEPSIS SOFA >10, sepsis with SOFA score >10 (n = 16). Results for the ratio are expressed as (Copies IGHM/Copies CD20). Right: receiver operating characteristic curve of IGHM/CD20 predicting presence of sepsis in the comparison (sepsis versus SIRS). For this comparison septic patients were considered as a single group.

IgM transcriptomic response in the presence/absence of sepsis. Left: comparison of immunoglobulin (Ig)M transcriptomic response between groups. HC, healthy control (n = 15); SIRS, systemic inflammatory response syndrome (n = 20); SEPSIS SOFA < =10, Sepsis with Sepsis-related Organ Failure Assessment score ≤10 (n = 39); SEPSIS SOFA >10, sepsis with SOFA score >10 (n = 16). Results for the ratio are expressed as (Copies IGHM/Copies CD20). Right: receiver operating characteristic curve of IGHM/CD20 predicting presence of sepsis in the comparison (sepsis versus SIRS). For this comparison septic patients were considered as a single group.

Abbreviations

ddPCR: droplet digital PCR; Ig: Immunoglobulin; PCR: Polymerase chain reaction; SIRS: Systemic inflammatory response syndrome.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

ET, JW, and JFBM helped with the study design, provided a critical review of the results and participated in article writing; RA, AAA, ARF, DAO, JIGH, and JME analyzed the data and participated in article writing; EC, MH, EGS, SS, and AMM recruited the patients, provided a critical review of the results and participated in article writing; LR and VI performed the molecular works and provided a critical review of the results. All authors read and approved the final manuscript.

Additional file 1

Additional file 1 is the supplemental methods. Click here for file
  4 in total

Review 1.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

2.  Absolute quantification by droplet digital PCR versus analog real-time PCR.

Authors:  Christopher M Hindson; John R Chevillet; Hilary A Briggs; Emily N Gallichotte; Ingrid K Ruf; Benjamin J Hindson; Robert L Vessella; Muneesh Tewari
Journal:  Nat Methods       Date:  2013-09-01       Impact factor: 28.547

3.  IMGT, the international ImMunoGeneTics information system.

Authors:  Marie-Paule Lefranc; Véronique Giudicelli; Chantal Ginestoux; Joumana Jabado-Michaloud; Géraldine Folch; Fatena Bellahcene; Yan Wu; Elodie Gemrot; Xavier Brochet; Jérôme Lane; Laetitia Regnier; François Ehrenmann; Gérard Lefranc; Patrice Duroux
Journal:  Nucleic Acids Res       Date:  2008-10-31       Impact factor: 16.971

4.  Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis.

Authors:  Sara Cajander; Anders Bäckman; Elisabet Tina; Kristoffer Strålin; Bo Söderquist; Jan Källman
Journal:  Crit Care       Date:  2013-10-06       Impact factor: 9.097

  4 in total
  4 in total

1.  Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis.

Authors:  Gloria Sanchez-Antolín; Carolina Almohalla-Alvarez; Pilar Bueno; Raquel Almansa; Verónica Iglesias; Lucia Rico; Alicia Ortega; Eva Muñoz-Conejero; Felix García-Pajares; Jesus F Bermejo-Martin
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

2.  Pulmonary transcriptomic responses indicate a dual role of inflammation in pneumonia development and viral clearance during 2009 pandemic influenza infection.

Authors:  Raquel Almansa; Pamela Martínez-Orellana; Lucía Rico; Verónica Iglesias; Alicia Ortega; Beatriz Vidaña; Jorge Martínez; Ana Expósito; María Montoya; Jesús F Bermejo-Martin
Journal:  PeerJ       Date:  2017-10-11       Impact factor: 2.984

3.  Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy.

Authors:  Stefanie Prohaska; Andrea Schirner; Albina Bashota; Andreas Körner; Gunnar Blumenstock; Helene A Haeberle
Journal:  J Intensive Care       Date:  2018-02-26

Review 4.  Digital PCR applications for the diagnosis and management of infection in critical care medicine.

Authors:  Irene Merino; Amanda de la Fuente; Marta Domínguez-Gil; José María Eiros; Ana P Tedim; Jesús F Bermejo-Martín
Journal:  Crit Care       Date:  2022-03-21       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.